XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
 12 Months Ended
Jan. 28, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense recognized under all of the Company's stock plans
The following summarizes the share-based compensation expense recognized under all of the Company’s stock plans (in thousands):
Year Ended
Jan 28, 2023Jan 29, 2022Jan 30, 2021
Stock options$2,709 $3,528 $3,430 
Stock awards/units17,478 17,385 15,110 
ESPP208 206 290 
Total share-based compensation expense$20,395 $21,119 $18,830 
Schedule of stock option activity under all of the Company's stock plans
The following summarizes the stock option activity under all of the Company’s stock plans:
Number of SharesWeighted Average
Exercise Price		Weighted Average
Remaining
Contractual
Term (Years)		Aggregate
Intrinsic
Value ($000’s)
Options outstanding at January 29, 20223,097,158 $16.58   
Granted— $—   
Exercised(242,647)$15.06   
Forfeited(166,782)$13.87   
Expired(118,100)$30.89   
Options outstanding at January 28, 20232,569,629 $16.24 5.46$17,915 
Exercisable at January 28, 20232,022,700 $16.89 5.12$13,045 
Schedule of weighted average assumptions used for stock option grants The following weighted average assumptions were used for grants:
Year Ended
Valuation AssumptionsJan 30, 2021
Risk-free interest rate0.3 %
Expected stock price volatility91.6 %
Expected dividend yield5.1 %
Expected life of stock options4.3 years
Schedule of nonvested stock awards/units activity under all of the Company's stock plans
The following summarizes the nonvested stock awards/units activity under all of the Company’s stock plans:
Number of Awards/UnitsWeighted Average Grant Date Fair Value
Nonvested at January 29, 20222,275,593 $16.72 
Granted1,049,886 $19.74 
Vested(799,229)$17.85 
Forfeited(185,958)$15.18 
Nonvested at January 28, 20232,340,292 $17.81 
Schedule of activity for nonvested performance-based units and nonvested market-based units
The following summarizes the activity for nonvested performance-based units and nonvested market-based units included in the above:
Performance-Based UnitsMarket-Based Units
Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Nonvested at January 29, 2022643,813 $18.78 877,813 $14.22 
Granted294,985 $20.34 156,845 $14.66 
Vested(314,453)$17.31 — $— 
Forfeited(11,718)$26.40 (87,871)$9.39 
Nonvested at January 28, 2023612,627 $20.14 946,787 $14.75 
Schedule of assumptions used for market-based nonvested stock units The following assumptions were used for the grants:
Year Ended
Valuation AssumptionsJan 28, 2023Jan 29, 2022Jan 30, 2021
Risk-free interest rate2.8 %0.6 %0.2 %
Expected stock price volatility71.3 %78.4 %62.8 %
Expected dividend yield— %— %— %
Expected life of market-based awards2.7 years3.5 years2.6 years
Schedule of weighted average assumptions used for ESPP
The fair value of stock compensation expense associated with the Company’s ESPP was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted average assumptions used for grants:
Year Ended
Valuation AssumptionsJan 28, 2023Jan 29, 2022Jan 30, 2021
Risk-free interest rate2.4 %0.0 %0.1 %
Expected stock price volatility55.4 %50.4 %145.9 %
Expected dividend yield5.3 %2.4 %1.4 %
Expected life of ESPP options3 months3 months3 months